CellWell record HH-342751
Safety and efficacy of low-density lipoprotein-lowering drugs in the elderly: a network meta-analysis of randomized controlled trials
Karmenia Jessica Kurnia Niaga; Pedro Arruda Supinto; Kevin Christian Tjandra; Alfianto Martin; Clement Drew; K Heri Nugroho Hario Seno; Felix; Laksmana Adi Krista Nugraha; Ferdy Tantowi
2026
In plain language
Moderate-intensity pitavastatin monotherapy showed highest safety profile; combined with ezetimibe, it was most effective for LDL reduction in elderly patients.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-342751
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.